Cytek Biosciences, Inc. (CTKB) Insider Trading Disclosures

Cytek Biosciences, Inc. (CTKB) is a publicly traded company on the Nasdaq, categorized under SIC 3826 (Laboratory Analytical Instruments). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.

Ticker: CTKB CIK: 1831915 Exchange: Nasdaq SIC 3826: Laboratory Analytical Instruments Fiscal Year End: 12/31 State: DE

Independent PCAOB Auditor

Explore PCAOB Audit Intelligence →
Audit Firm Deloitte & Touche LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerJulian Valencia
Audit LocationSan Jose, California, United States

Latest SEC EDGAR Filings

Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions
Form Filing Date Reporting Period Description Accession Number Actions
8-K 2026-09-29 2026-09-23 8-K 0001193125-26-407330 View SEC Doc Filr Page
144 2026-09-02 — 144 Filing 0001950047-26-008998 View SEC Doc Filr Page
8-K 2026-08-24 2026-08-21 8-K 0001193125-26-361705 View SEC Doc Filr Page
4 2026-08-20 2026-08-18 4 Filing 0001872873-26-000006 View SEC Doc Filr Page
4 2026-08-20 2026-08-18 4 Filing 0001878824-26-000004 View SEC Doc Filr Page
4 2026-08-20 2026-08-18 4 Filing 0001181190-26-000007 View SEC Doc Filr Page
4 2026-08-20 2026-08-18 4 Filing 0001515140-26-000005 View SEC Doc Filr Page
4 2026-08-20 2026-08-18 4 Filing 0001337252-26-000005 View SEC Doc Filr Page
4 2026-08-20 2026-08-18 4 Filing 0001874041-26-000009 View SEC Doc Filr Page
4 2026-08-12 2026-08-10 4 Filing 0002141966-26-000002 View SEC Doc Filr Page
SCHEDULE 13G/A 2026-08-06 — SCHEDULE 13G/A Filing 0001104659-26-092212 View SEC Doc Filr Page
10-Q 2026-08-05 2026-06-30 10-Q 0001628280-26-053496 View SEC Doc Filr Page
8-K 2026-08-05 2026-08-05 8-K 0001193125-26-335212 View SEC Doc Filr Page
SCHEDULE 13G 2026-08-04 — SCHEDULE 13G Filing 0001386060-26-000050 View SEC Doc Filr Page
8-K 2026-07-15 2026-07-09 8-K 0001193125-26-304789 View SEC Doc Filr Page
SCHEDULE 13G/A 2026-07-08 — SCHEDULE 13G/A Filing 0002012383-26-001934 View SEC Doc Filr Page
3 2026-06-30 2026-06-29 3 Filing 0002141966-26-000001 View SEC Doc Filr Page
8-K 2026-06-25 2026-06-18 8-K 0001193125-26-282871 View SEC Doc Filr Page
4 2026-06-16 2026-06-12 4 Filing 0001874041-26-000007 View SEC Doc Filr Page
8-K 2026-06-16 2026-06-10 8-K 0001193125-26-272582 View SEC Doc Filr Page
4 2026-06-12 2026-06-10 4 Filing 0001873083-26-000001 View SEC Doc Filr Page
4 2026-06-12 2026-06-10 4 Filing 0001181190-26-000005 View SEC Doc Filr Page
3 2026-06-12 2026-06-10 3 Filing 0001181190-26-000004 View SEC Doc Filr Page
4 2026-06-12 2026-06-10 4 Filing 0001337252-26-000003 View SEC Doc Filr Page
4 2026-06-12 2026-06-10 4 Filing 0001902959-26-000001 View SEC Doc Filr Page